Annual Total Long Term Liabilities
$9.87 M
+$2.12 M+27.28%
31 March 2024
Summary:
Acasti Pharma annual total long term liabilities is currently $9.87 million, with the most recent change of +$2.12 million (+27.28%) on 31 March 2024. During the last 3 years, it has risen by +$4.65 million (+89.17%). ACST annual total long term liabilities is now -42.23% below its all-time high of $17.09 million, reached on 31 March 2022.ACST Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$6.54 M
-$1.21 M-15.64%
30 September 2024
Summary:
Acasti Pharma quarterly total long term liabilities is currently $6.54 million, with the most recent change of -$1.21 million (-15.64%) on 30 September 2024. Over the past year, it has dropped by -$3.53 million (-35.03%). ACST quarterly long term liabilities is now -72.22% below its all-time high of $23.55 million, reached on 31 December 2019.ACST Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | -35.0% |
| 3 y3 years | +89.2% | +486.1% |
| 5 y5 years | -19.0% | -64.1% |
ACST Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.2% | +89.2% | -61.7% | +2340.7% |
| 5 y | 5 years | -42.2% | +300.7% | -72.2% | +2340.7% |
| alltime | all time | -42.2% | -72.2% |
Acasti Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.54 M(-15.6%) |
| June 2024 | - | $7.75 M(-21.5%) |
| Mar 2024 | $9.87 M(+27.3%) | $9.87 M(+1.4%) |
| Dec 2023 | - | $9.73 M(-3.3%) |
| Sept 2023 | - | $10.07 M(+42.7%) |
| June 2023 | - | $7.06 M(-9.0%) |
| Mar 2023 | $7.76 M(-54.6%) | $7.76 M(-53.4%) |
| Dec 2022 | - | $16.65 M(-1.7%) |
| Sept 2022 | - | $16.94 M(+0.7%) |
| June 2022 | - | $16.82 M(-1.6%) |
| Mar 2022 | $17.09 M(+227.5%) | $17.09 M(+6276.9%) |
| Dec 2021 | - | $268.00 K(-76.0%) |
| Sept 2021 | - | $1.12 M(-76.0%) |
| June 2021 | - | $4.65 M(-10.9%) |
| Mar 2021 | $5.22 M(+111.8%) | $5.22 M(+123.0%) |
| Dec 2020 | - | $2.34 M(+93.7%) |
| Sept 2020 | - | $1.21 M(-61.4%) |
| June 2020 | - | $3.13 M(+26.9%) |
| Mar 2020 | $2.46 M(-79.8%) | $2.46 M(-89.5%) |
| Dec 2019 | - | $23.55 M(+29.1%) |
| Sept 2019 | - | $18.23 M(+36.9%) |
| June 2019 | - | $13.32 M(+9.3%) |
| Mar 2019 | $12.18 M(+95.7%) | $12.18 M(+9.3%) |
| Dec 2018 | - | $11.15 M(-33.2%) |
| Sept 2018 | - | $16.69 M(+140.5%) |
| June 2018 | - | $6.94 M(+11.5%) |
| Mar 2018 | $6.22 M(+414.0%) | $6.22 M(+8.8%) |
| Dec 2017 | - | $5.72 M(+355.0%) |
| Sept 2017 | - | $1.26 M(+6.7%) |
| June 2017 | - | $1.18 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $1.21 M(+952.1%) | - |
| Nov 2016 | - | $44.70 K(+0.7%) |
| Aug 2016 | - | $44.40 K(-53.2%) |
| May 2016 | - | $94.80 K(-17.6%) |
| Feb 2016 | $115.10 K(-93.9%) | $115.10 K(-43.1%) |
| Nov 2015 | - | $202.40 K(-57.1%) |
| Aug 2015 | - | $472.20 K(-9.6%) |
| May 2015 | - | $522.20 K(-72.3%) |
| Feb 2015 | $1.88 M(-81.3%) | $1.88 M(+30.5%) |
| Nov 2014 | - | $1.44 M(-77.1%) |
| Aug 2014 | - | $6.31 M(+4.6%) |
| May 2014 | - | $6.03 M(-40.0%) |
| Feb 2014 | $10.05 M(>+9900.0%) | $10.05 M(>+9900.0%) |
| Nov 2013 | - | $0.00(0.0%) |
| Aug 2013 | - | $0.00(0.0%) |
| May 2013 | - | $0.00(0.0%) |
| Feb 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | - | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) |
| Feb 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | - | $0.00(-100.0%) |
| May 2011 | - | $182.80 K(>+9900.0%) |
| Feb 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | - | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | $0.00 | $0.00(0.0%) |
| Nov 2009 | - | $0.00 |
FAQ
- What is Acasti Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acasti Pharma?
- What is Acasti Pharma annual total long term liabilities year-on-year change?
- What is Acasti Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acasti Pharma?
- What is Acasti Pharma quarterly long term liabilities year-on-year change?
What is Acasti Pharma annual total long term liabilities?
The current annual total long term liabilities of ACST is $9.87 M
What is the all time high annual total long term liabilities for Acasti Pharma?
Acasti Pharma all-time high annual total long term liabilities is $17.09 M
What is Acasti Pharma annual total long term liabilities year-on-year change?
Over the past year, ACST annual total long term liabilities has changed by +$2.12 M (+27.28%)
What is Acasti Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of ACST is $6.54 M
What is the all time high quarterly long term liabilities for Acasti Pharma?
Acasti Pharma all-time high quarterly total long term liabilities is $23.55 M
What is Acasti Pharma quarterly long term liabilities year-on-year change?
Over the past year, ACST quarterly total long term liabilities has changed by -$3.53 M (-35.03%)